Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.53 |
| ▸ | MAOB | P27338 | 4/20 | 0.52 |
| ▸ | MAOA | P21397 | 2/20 | 0.52 |
| ▸ | PDE4A | P27815 | 1/20 | 0.51 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.50 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 2/20 | 0.44 |
| ▸ | CNR1 | P21554 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | GFER | P55789 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.42 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10842083 | 0.93 | SLC6A2 (0.55) | SLC6A2SLC6A4SLC6A3MAOBMAOA | |
| SCHEMBL19744645 | 0.85 | SLC6A2 (0.49) | SLC6A2SLC6A4SLC6A3MAOBMAOA | |
| SCHEMBL5294122 | 0.83 | ALDH1A1 (0.52) | SLC6A2TAAR1ALDH1A1CYP3A4 | |
| SCHEMBL17294369 | 0.83 | ALDH1A1 (0.52) | SLC6A2TAAR1ALDH1A1CYP3A4 | |
| SCHEMBL8126114 | 0.83 | MAOA (0.59) | SLC6A2SLC6A4SLC6A3MAOBMAOA | |
| SCHEMBL29260543 | 0.83 | MAOB (0.52) | MAOBMAOASOAT1EPHX1TSHR | |
| SCHEMBL924819 | 0.81 | SLC6A2 (0.74) | SLC6A2SLC6A4SLC6A3MAOAHTR2A | |
| SCHEMBL318537 | 0.81 | SLC6A2 (0.74) | SLC6A2SLC6A4SLC6A3MAOAHTR2A | |
| SCHEMBL8352649 | 0.81 | SOAT1 (0.53) | MAOBMAOASOAT1EPHX1 | |
| SCHEMBL9322166 | 0.81 | MAOB (0.50) | SLC6A2SLC6A4SLC6A3MAOBMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114381095-B | High-gas-resistance high-temperature-cooking-resistant transparent resin and preparation method and application thereof | 佛山市辉鸿塑胶实业有限公司 | 2023-04-18 | — | — | CN | claimed |
| CN-114381095-B | High-gas-resistance high-temperature-cooking-resistant transparent resin and preparation method and application thereof | 佛山市辉鸿塑胶实业有限公司 | 2023-04-18 | — | — | CN | disclosed |
| US-20140155382-A1 | ANTI-VIRAL COMPOUNDS | ABBVIE INC. (US) | 2014-06-05 | — | — | US | disclosed |
| US-20140155382-A1 | ANTI-VIRAL COMPOUNDS | ABBVIE INC. (US) | 2014-06-05 | — | — | US | disclosed |
| US-20140155382-A1 | ANTI-VIRAL COMPOUNDS | ABBVIE INC. (US) | 2014-06-05 | — | — | US | disclosed |
| EP-2651924-A1 | ANTI-VIRAL COMPOUNDS | Abbvie Inc. (US) | 2013-10-23 | — | — | EP | disclosed |
| WO-2012083164-A1 | ANTI-VIRAL COMPOUNDS | ABBOTT LABORATORIES (US) | 2012-06-21 | — | — | WO | disclosed |
| WO-2012083164-A1 | ANTI-VIRAL COMPOUNDS | ABBOTT LABORATORIES (US) | 2012-06-21 | — | — | WO | disclosed |
| US-20120115918-A1 | Anti-Viral Compounds | ABBOTT LABORATORIES (US) | 2012-05-10 | — | — | US | disclosed |
| US-20120115918-A1 | Anti-Viral Compounds | ABBOTT LABORATORIES (US) | 2012-05-10 | — | — | US | disclosed |
| US-20120115918-A1 | Anti-Viral Compounds | ABBOTT LABORATORIES (US) | 2012-05-10 | — | — | US | disclosed |
| US-8138278-B2 | Polymer compositions and methods of making and using same | POLYMERIGHT, INC. (US) | 2012-03-20 | — | — | US | disclosed |
| US-20110152492-A1 | Polymer Compositions and Methods of Making and Using Same | POLYMERIGHT, INC. (US) | 2011-06-23 | — | — | US | disclosed |
| WO-2011008480-A1 | POLYMER COMPOSITIONS AND METHODS OF MAKING AND USING SAME | POLYMERIGHT, INC. (US) | 2011-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120115918-A1 | Anti-Viral Compounds | HAVCR2, EIF2AK2, MAVS | SLC6A2 4436/4885SLC6A4 4489/4885SLC6A3 4268/4885 |
| US-20140155382-A1 | ANTI-VIRAL COMPOUNDS | HAVCR2, EIF2AK2, MAVS | SLC6A2 4436/4885SLC6A4 4489/4885SLC6A3 4268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.